Building Blocks for the Screening of Histone Deacetylase Inhibitors Using μSPOT

Carlos Moreno-Yruela1, Vita Sereikaite2

  • 1Laboratory of Biophysical Chemistry of Macromolecules (LCBM), Institute of Chemical Sciences and Engineering (ISIC), School of Basic Sciences (SB), EPFL, Lausanne, Switzerland. carlos.morenoyruela@epfl.ch.

Summary

Researchers developed a new method to create selective histone deacetylase (HDAC) inhibitors. This approach enables the screening of diverse peptide libraries for potential cancer therapies and treatments for other diseases.

Related Concept Videos